Plasmacytoid Dendritic Cell Impairment in Metastatic Melanoma by Lactic Acidosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasmacytoid Dendritic Cell Impairment in Metastatic Melanoma by Lactic Acidosis
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 8, Pages 2085
Publisher
MDPI AG
Online
2020-07-30
DOI
10.3390/cancers12082085
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma
- (2020) Matilde Monti et al. Cells
- Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis
- (2019) G. Comito et al. ONCOGENE
- Interferons α and β in cancer: therapeutic opportunities from new insights
- (2019) Ernest C. Borden NATURE REVIEWS DRUG DISCOVERY
- Lactate Is a Natural Suppressor of RLR Signaling by Targeting MAVS
- (2019) Weina Zhang et al. CELL
- UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity
- (2019) Olivia Majer et al. NATURE
- Release from UNC93B1 reinforces the compartmentalized activation of select TLRs
- (2019) Olivia Majer et al. NATURE
- Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells
- (2019) Deblina Raychaudhuri et al. Frontiers in Immunology
- European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019
- (2019) Claus Garbe et al. EUROPEAN JOURNAL OF CANCER
- Metabolic heterogeneity confers differences in melanoma metastatic potential
- (2019) Alpaslan Tasdogan et al. NATURE
- Culture supernatants of oral cancer cells induce impaired IFN-α production of pDCs partly through the down-regulation of TLR-9 expression
- (2018) Nannan Han et al. ARCHIVES OF ORAL BIOLOGY
- Downregulation of Membrane Trafficking Proteins and Lactate Conditioning Determine Loss of Dendritic Cell Function in Lung Cancer
- (2018) Nicoletta Caronni et al. CANCER RESEARCH
- The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells
- (2018) Vaclav Janovec et al. Frontiers in Immunology
- Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial
- (2018) Hansje-Eva Teulings et al. OncoImmunology
- Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells
- (2018) Florian Wimmers et al. Nature Communications
- Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600–Mutated Metastatic Melanoma
- (2018) Axel Hauschild et al. JAMA Oncology
- Collapse of the Plasmacytoid Dendritic Cell Compartment in Advanced Cutaneous Melanomas by Components of the Tumor Cell Secretome
- (2018) Raffaella Vescovi et al. Cancer Immunology Research
- Innate immune cell infiltration in melanoma metastases affects survival and is associated with BRAFV600E mutation status
- (2018) Nina Dabrosin et al. MELANOMA RESEARCH
- Survival of patients with advanced metastatic melanoma: the impact of novel therapies–update 2017
- (2017) Selma Ugurel et al. EUROPEAN JOURNAL OF CANCER
- Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications
- (2017) Grant M. Fischer et al. Pigment Cell & Melanoma Research
- Mapping the human DC lineage through the integration of high-dimensional techniques
- (2017) Peter See et al. SCIENCE
- Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence
- (2017) Mari F.C.M. van den Hout et al. Cancer Immunology Research
- Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
- (2016) S Diem et al. BRITISH JOURNAL OF CANCER
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Cutting Edge: Critical Role of Glycolysis in Human Plasmacytoid Dendritic Cell Antiviral Responses
- (2016) Gagan Bajwa et al. JOURNAL OF IMMUNOLOGY
- Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma
- (2016) Francesco Sabbatino et al. JNCI-Journal of the National Cancer Institute
- Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials
- (2016) Georgina V Long et al. LANCET ONCOLOGY
- Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma
- (2016) Francesco Sabbatino et al. JNCI-Journal of the National Cancer Institute
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma
- (2015) Ines Chevolet et al. Journal of Translational Medicine
- BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma
- (2015) S. D. Bradley et al. Cancer Immunology Research
- Evaluating biomarkers in melanoma
- (2015) Panagiotis Karagiannis et al. Frontiers in Oncology
- Management of melanoma
- (2014) P. Corrie et al. BRITISH MEDICAL BULLETIN
- Tumor cells hijack macrophages via lactic acid
- (2014) Vincenzo Bronte IMMUNOLOGY AND CELL BIOLOGY
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Imiquimod Inhibits Melanoma Development by Promoting pDC Cytotoxic Functions and Impeding Tumor Vascularization
- (2014) Caroline Aspord et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials
- (2013) J. D. Wolchok et al. ANNALS OF ONCOLOGY
- Inhibition of both BRAF and MEK in BRAFV600E mutant melanoma restores compromised dendritic cell (DC) function while having differential direct effects on DC properties
- (2013) Patrick A. Ott et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Numerical defect of circulating dendritic cell subsets and defective dendritic cell generation from monocytes of patients with advanced melanoma
- (2013) Alessandra Failli et al. CANCER LETTERS
- Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment
- (2013) I. Le Mercier et al. CANCER RESEARCH
- BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
- (2013) D. T. Frederick et al. CLINICAL CANCER RESEARCH
- Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells
- (2013) Vanja Sisirak et al. INTERNATIONAL JOURNAL OF CANCER
- Plasmacytoid Dendritic Cells Support Melanoma Progression by Promoting Th2 and Regulatory Immunity through OX40L and ICOSL
- (2013) C. Aspord et al. Cancer Immunology Research
- Impact of MAPK Pathway Activation in BRAFV600 Melanoma on T Cell and Dendritic Cell Function
- (2013) Patrick A. Ott et al. Frontiers in Immunology
- ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4+ T Cells
- (2012) J. Faget et al. CANCER RESEARCH
- BRAF(V600) Inhibitor GSK2118436 Targeted Inhibition of Mutant BRAF in Cancer Patients Does Not Impair Overall Immune Competency
- (2012) D. S. Hong et al. CLINICAL CANCER RESEARCH
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma
- (2011) James S. Wilmott et al. CLINICAL CANCER RESEARCH
- Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer
- (2011) Noriaki Sunaga et al. INTERNATIONAL JOURNAL OF CANCER
- Human C-type Lectin Domain Family 4, Member C (CLEC4C/BDCA-2/CD303) Is a Receptor for Asialo-galactosyl-oligosaccharides
- (2011) Elena Riboldi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function
- (2010) A. Boni et al. CANCER RESEARCH
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
- (2010) Cesar A. Corzo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction
- (2009) Wei Cao et al. JOURNAL OF EXPERIMENTAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search